This template provides a standardized, weighted scoring framework for evaluating imaging CRO vendors during Request for Proposal (RFP) processes, preferred vendor list establishment, and study-specific vendor selection. It is grounded in the FDA’s Clinical Trial Imaging Endpoint Process Standards (Guidance for Industry, 2018) and the ICH E6(R3) Guideline for Good Clinical Practice (effective January 2025), and reflects pharmaceutical industry best practices for imaging vendor qualification.